Does the autonomic nervous system play a role in the development of insulin resistance? A study on heart rate variability in first-degree relatives of Type 2 diabetes patients and control subjects

Diabetic Medicine

Volumn 20, Issue 5, 2003, Pages 399-405

  Lindmark, S ^a   Wiklund, U ^a   Bjerle, P ^a   Eriksson, Jan W ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Autonomic nervous system; Heart rate variability; Insulin sensitivity; Spectral analysis; Type 2 diabetes

Indexed keywords

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HEART RATE VARIABILITY; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PATHOGENESIS; PHYSICAL STRESS; RELATIVE; SYMPATHETIC TONE;

ADULT; ARRHYTHMIA; AUTONOMIC NERVOUS SYSTEM DISEASES; BLOOD GLUCOSE; BODY MASS INDEX; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN RESISTANCE; MALE; PEDIGREE;

EID: 0038530767     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2003.00920.x     Document Type: Article

References (33)

1. Beck-Nielsen H Groop LC. Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus. J Clin Invest 1994; 94: 1714-1721.
2. Bonadonna RC, Del Prato S, Bonora E, Saccomani MP, Gulli G, Natali A et al. Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes 1996; 45: 915-925.
3. Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C et al. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 1989; 321: 337-343.
4. Vestergaard H, Bjorbaek C, Andersen PH, Bak JF, Pedersen O. Impaired expression of glycogen synthase mRNA in skeletal muscle of NIDDM patients. Diabetes 1991; 40: 1740-1745.
5. Surwit RS, Feinglos MN. Stress and autonomic nervous system in type II diabetes. A hypothesis. Diabetes Care 1988; 11: 83-85.
6. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
7. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-194.
8. Daly PA, Landsberg L. Hypertension in obesity and NIDDM. Role of insulin and sympathetic nervous system. Diabetes Care 1991; 14: 240-248.
9. Lembo G, Vecchione C, Iaccarino G, Trimarco B. The crosstalk between insulin and the sympathetic nervous system: possible implications in the pathogenesis of essential hypertension. Blood Press Suppl 1996; 1: 38-42.
10. Ortiz-Alonso FJ, Herman WH, Zobel DL, Perry TJ, Smith MJ, Halter JB. Effect of epinephrine on pancreatic beta-cell and alpha-cell function in patients with NIDDM. Diabetes 1991; 40: 1194-1202.
11. Wales JK. Does psychological stress cause diabetes? Diabet Med 1995; 12: 109-112.
12. Surwit RS, Schneider MS. Role of stress in the etiology and treatment of diabetes mellitus. Psychosom Med 1993; 55: 380-393.
13. Kuhn CM, Cochrane C, Feinglos MN, Surwit RS. Exaggerated peripheral responses to catecholamines contributes to stress-induced hyperglycemia in the ob/ob mouse. Pharmacol Biochem Behav 1987; 26: 491-495.
14. Bruce DG, Chisholm DJ, Storlien LH, Kraegen EW, Smythe GA. The effects of sympathetic nervous system activation and psychological stress on glucose metabolism and blood pressure in subjects with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992; 35: 835-843.
15. Laitinen T, Vauhkonen IK, Niskanen LK, Hartikainen JE, Lansimies EA, Uusitupa MI et al. Power spectral analysis of heart rate variability during hyperinsulinemia in nondiabetic offspring of type 2 diabetic patients: evidence for possible early autonomic dysfunction in insulin-resistant subjects. Diabetes 1999; 48: 1295-1299.
16. Malliani A, Lombardi F, Pagani M. Power spectrum analysis of heart rate variability: a tool to explore neural regulatory mechanisms. Br Heart J 1994; 71: 1-2.
17. Carvalho E, Jansson PA, Axelsen M, Eriksson JW, Huang X, Groop L et al. Low cellular IRS 1 gene and protein expression predict insulin resistance and NIDDM. FASEB J 1999; 13: 2173-2178.
18. Alberti KG, Zimmet PZ. New diagnostic criteria and classification of diabetes - again? Diabet Med 1998; 15: 535-536.
19. Lukaski HC, Bolonchuk WW, Hall CB, Siders WA. Validation of tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol 1986; 60: 1327-1332.
20. Blom H, Andersson C, Olofsson BO, Bjerle P, Wiklund U, Lithner F. Assessment of autonomic nerve function in acute intermittent porphyria; a study based on spectral analysis of heart rate variability. J Entern Med 1996; 240: 73-79.
21. deBoer RW, Karemaker JM, Strackee J. Hemodynamic fluctuations and baroreflex sensitivity in humans: a beat-to-beat model. Am J Physiol 1987; 253: H680-689.
22. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 1996; 17: 354-381.
23. Luutonen S, Antila K, Neuvonen P, Raiha I, Rajala T, Sourander L. Spectral analysis of heart rate variability in evaluation of sympathetic function in elderly subjects. Age Ageing 1994; 23: 473-477.
24. Eckberg DL. Sympathovagal balance: a critical appraisal. Circulation 1997; 96: 3224-3232.
25. Eriksson JW, Smith U, Waagstein F, Wysocki M, Jansson PA. Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary, phenomenon? Diabetes 1999; 48: 1572-1578.
26. Burén J, Lindmark S, Renström F, Eriksson JW. In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients. Metabolism 2003; 52: 239-245.
27. Takayama S, Sakura H, Katsumori K, Wasada T, Iwamoto Y. A possible involvement of parasympathetic neuropathy on insulin resistance in patients with type 2 diabetes. Diabetes Care 2001; 24: 968-969.
28. Lautt WW. The HISS story overview: a novel hepatic neurohumoral regulation of peripheral insulin sensitivity in health and diabetes. Can J Physiol Pharmacol 1999; 77: 553-562.
29. Takayama S, Legate DJ, Lautt WW. Dose-related atropine-induced insulin resistance: comparing intraportal versus intravenous administration. Proc West Pharmacol Soc 2000; 43: 33-34.
30. Gottsater A, Ahmed M, Fernlund P, Sundkvist G. Autonomic neuropathy in Type 2 diabetic patients is associated with hyperinsulinaemia and hypertriglyceridaemia. Diabet Med 1999; 16: 49-54.
31. Scherrer U, Sartori C. Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation 1997; 96: 4104-4113.
32. Benthem L, Keizer K, Wiegman CH, de Boer SF, Strubbe JH, Steffens AB et al. Excess portal venous long-chain fatty acids induce syndrome X via HPA axis and sympathetic activation. Am J Physiol Endocrinol Metab 2000; 279: E1286-1293.
33. Spraul M, Ravussin E, Fontvieille AM, Rising R, Larson DE, Anderson EA. Reduced sympathetic nervous activity. A potential mechanism predisposing to body weight gain. J Clin Invest 1993; 92: 1730-1735.